Clinical Pharmacokinetics of Sulfobutylether‐β‐Cyclodextrin in Patients With Varying Degrees of Renal Impairment

Delafloxacin, a fluoroquinolone, has activity against Gram‐positive organisms including methicillin‐resistant S aureus and fluoroquinolone‐susceptible and ‐resistant Gram‐negative organisms. The intravenous formulation of delafloxacin contains the excipient sulfobutylether‐β‐cyclodextrin (SBECD), wh...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Pharmacol
Autors principals: Hoover, Randall K., Alcorn, Harry, Lawrence, Laura, Paulson, Susan K., Quintas, Megan, Luke, David R., Cammarata, Sue K.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Special Populations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6718009/
https://ncbi.nlm.nih.gov/pubmed/29578585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1077
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars